TP53 mutation and haplotype analysis of two large African American families

Two large apparently unrelated African American families with a high incidence of breast cancer and other tumors characteristic of Li‐Fraumeni breast sarcoma cancer family syndrome were studied. Mutation screening revealed that in both families the affected members carried a germline mutation of the...

Full description

Saved in:
Bibliographic Details
Published inHuman mutation Vol. 14; no. 3; pp. 216 - 221
Main Authors Hung, Jaclyn, Mims, Betsy, Lozano, Guillermina, Strong, Louise, Harvey, Carolyn, Chen, Tina T.-Y., Stastny, Victor, Tomlinson, Gail
Format Journal Article
LanguageEnglish
Published New York John Wiley & Sons, Inc 1999
Hindawi Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Two large apparently unrelated African American families with a high incidence of breast cancer and other tumors characteristic of Li‐Fraumeni breast sarcoma cancer family syndrome were studied. Mutation screening revealed that in both families the affected members carried a germline mutation of the TP53 gene at codon 133 (ATG→ ACG, M133T). In order to determine whether an ancestral haplotype was shared by these two families, polymorphic markers within and flanking the TP53 gene were studied. Haplotype analysis using five markers revealed an identical haplotype shared by the two families. Loss of heterozygosity at the TP53 locus in the probands' tumor tissues from each family was observed; in each case, the retained allele carried the common haplotype. The frequency of this haplotype in the general African American population is <0.003. This unique haplotype, combined with the rare TP53 mutation, suggests that these African American families share a common ancestry. This finding suggests that other African Americans may be carriers of this mutation and thus may be at risk of early‐onset breast cancer or other cancers characteristic of the Li‐Fraumeni breast sarcoma cancer family syndrome. The finding of recurring mutations in African Americans may facilitiate carrier screening and identification in this population. Hum Mutat 14:216–221, 1999. © 1999 Wiley‐Liss, Inc.
Bibliography:ark:/67375/WNG-LH1R0RCC-L
ArticleID:HUMU4
istex:4869C0F3663D10934898920F4FB7A25AFD5A9BF4
DAMD - No. 17-96-1-6206
National Institutes of Health - No. PO1-CA34936
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1059-7794
1098-1004
DOI:10.1002/(SICI)1098-1004(1999)14:3<216::AID-HUMU4>3.0.CO;2-X